In:
Arteriosclerosis, Thrombosis, and Vascular Biology, Ovid Technologies (Wolters Kluwer Health), Vol. 20, No. 6 ( 2000-06), p. 1682-1687
Abstract:
Abstract —Elevated levels of plasminogen activator inhibitor-1 (PAI-1) are characteristic for obesity and are associated with increased risk of thromboembolic complications. PAI-1 recently was reported to be expressed and secreted by human adipocytes, but little is known about regulation of PAI-1 in human adipose tissue. Therefore, we examined the effects of selected cytokines present in adipose tissue on expression and secretion of PAI-1 in in vitro, differentiated subcutaneous human adipocytes in primary culture. Transforming growth factor-β1 (TGF-β1) increased PAI-1 secretion in a dose- and time-dependent manner. PAI-1 protein increased by 3.2-fold and PAI-1 mRNA by 1.9-fold after a 6-hour exposure to 400 pmol/L TGF-β1. This effect is probably mediated by TGF-β1 type 2 and 3 receptors, which were found to be expressed in cultured human adipocytes. Moreover, TNF-α and interkeukin-1β (IL-1β) also exerted a stimulatory effect on PAI-1 release and increased PAI-1 mRNA levels. As assessed by a semiquantitative reverse transcription—polymerase chain reaction technique, TGF-β1 mRNA is expressed by differentiation of human preadipocytes and is moderately upregulated by TNF-α and IL-1β. In conclusion, our results clearly indicate that TGF-β1 is a potent inducer of PAI-1 production in subcutaneous human adipocytes. In addition, data suggest that TNF-α and IL-1β also have stimulatory effects on PAI-1 protein secretion and may contribute to the elevated PAI-1 levels observed in obesity.
Type of Medium:
Online Resource
ISSN:
1079-5642
,
1524-4636
DOI:
10.1161/01.ATV.20.6.1682
Language:
English
Publisher:
Ovid Technologies (Wolters Kluwer Health)
Publication Date:
2000
detail.hit.zdb_id:
1494427-3
